<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33809730</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>15</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>16</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">437</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom11030437</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) affects motor neurons in the cerebral cortex, brainstem and spinal cord and leads to death due to respiratory failure within three to five years. Although the clinical symptoms of this disease were first described in 1869 and it is the most common motor neuron disease and the most common neurodegenerative disease in middle-aged individuals, the exact etiopathogenesis of ALS remains unclear and it remains incurable. However, free oxygen radicals (i.e., molecules containing one or more free electrons) are known to contribute to the pathogenesis of this disease as they very readily bind intracellular structures, leading to functional impairment. Antioxidant enzymes, which are often metalloenzymes, inactivate free oxygen radicals by converting them into a less harmful substance. One of the most important antioxidant enzymes is Cu<sup>2+</sup>Zn<sup>2+</sup> superoxide dismutase (SOD1), which is mutated in 20% of cases of the familial form of ALS (fALS) and up to 7% of sporadic ALS (sALS) cases. In addition, the proper functioning of catalase and glutathione peroxidase (GPx) is essential for antioxidant protection. In this review article, we focus on the mechanisms through which these enzymes are involved in the antioxidant response to oxidative stress and thus the pathogenesis of ALS and their potential as therapeutic targets.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hemerkov&#xe1;</LastName><ForeName>Pavl&#xed;na</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vali&#x161;</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, Charles University, Faculty of Medicine and University Hospital Hradec Kralove, 500 05 Hradec Kralove, Czech Republic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000975">Antioxidants</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008667">Metalloproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000975" MajorTopicYN="N">Antioxidants</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008667" MajorTopicYN="N">Metalloproteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="Y">Oxidative Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">catalase</Keyword><Keyword MajorTopicYN="N">glutathione peroxidase</Keyword><Keyword MajorTopicYN="N">superoxide dismutase</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33809730</ArticleId><ArticleId IdType="pmc">PMC8002298</ArticleId><ArticleId IdType="doi">10.3390/biom11030437</ArticleId><ArticleId IdType="pii">biom11030437</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wijesekera L.C., Leigh P.N. Amyotrophic lateral sclerosis. Orphanet J. Rare Dis. 2009;4:3. doi: 10.1186/1750-1172-4-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1172-4-3</ArticleId><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>Niedermeyer S., Murn M., Choi P.J. Respiratory Failure in Amyotrophic Lateral Sclerosis. Chest. 2019;155:401&#x2013;408. doi: 10.1016/j.chest.2018.06.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.06.035</ArticleId><ArticleId IdType="pubmed">29990478</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Logroscino G., Traynor B.J., Collins J., Simeone J.C., Goldstein L.A., White L.A. Global epidemiology of amyotrophic lateral sclerosis: A systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2013;130. doi: 10.1159/000351153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000351153</ArticleId><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomen-Hoerth C., Murphy J., Langmore S., Kramer J.H., Olney R.K., Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology. 2003;60:1094&#x2013;1097. doi: 10.1212/01.WNL.0000055861.95202.8D.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.WNL.0000055861.95202.8D</ArticleId><ArticleId IdType="pubmed">12682312</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J. The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2008;9:323&#x2013;338. doi: 10.1080/17482960802372371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802372371</ArticleId><ArticleId IdType="pubmed">18752088</ArticleId></ArticleIdList></Reference><Reference><Citation>Knirsch U.I., Bachus R., Gosztonyi G., Zschenderlein R., Ludolph A.C. Clinicopathological study of atypical motor neuron disease with vertical gaze palsy and ballism. Acta Neuropathol. 2000;100:342&#x2013;346. doi: 10.1007/s004010000185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004010000185</ArticleId><ArticleId IdType="pubmed">10965806</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradat P.F., Salachas F., Lacomblez L., Patte N., Leforestier N., Gaura V., Meininger V. Association of chorea and motor neuron disease. Mov. Disord. 2002;17:419&#x2013;420. doi: 10.1002/mds.10039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.10039</ArticleId><ArticleId IdType="pubmed">11921138</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Pradat P.F., Ludolph A.C., Loeffler J.P. Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol. 2011;10:75&#x2013;82. doi: 10.1016/S1474-4422(10)70224-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70224-6</ArticleId><ArticleId IdType="pubmed">21035400</ArticleId></ArticleIdList></Reference><Reference><Citation>Milani P., Ambrosi G., Gammoh O., Blandini F., Cereda C. SOD1 and DJ-1 converge at Nrf2 pathway: A clue for antioxidant therapeutic potential in neurodegeneration. Oxid. Med. Cell Longev. 2013;2013:836760. doi: 10.1155/2013/836760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/836760</ArticleId><ArticleId IdType="pmc">PMC3745953</ArticleId><ArticleId IdType="pubmed">23983902</ArticleId></ArticleIdList></Reference><Reference><Citation>Fantone J.C., Ward P.A. Role of oxygen-derived free radicals and metabolites in leukocyte-dependent inflammatory reactions. Am. J. Pathol. 1982;107:395&#x2013;418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1916241</ArticleId><ArticleId IdType="pubmed">6282132</ArticleId></ArticleIdList></Reference><Reference><Citation>Vile G.F., Tyrrell R.M. UVA radiation-induced oxidative damage to lipids and proteins in vitro and in Human skin fibroblasts is dependent on iron and singlet oxygen. Free Radic. Biol. Med. 1995;18:721&#x2013;730. doi: 10.1016/0891-5849(94)00192-M.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0891-5849(94)00192-M</ArticleId><ArticleId IdType="pubmed">7750796</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Wang X., Vikash V., Ye Q., Wu D., Liu Y., Dong W. ROS and ROS-Mediated Cellular Signaling. Oxid. Med. Cell Longev. 2016;2016:4350965. doi: 10.1155/2016/4350965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/4350965</ArticleId><ArticleId IdType="pmc">PMC4779832</ArticleId><ArticleId IdType="pubmed">26998193</ArticleId></ArticleIdList></Reference><Reference><Citation>Tormos K.V., Anso E., Hamanaka R.B., Eisenbart J., Joseph J., Kalyanaraman B., Chandel N.S. Mitochondrial complex III ROS regulate adipocyte differentiation. Cell Metab. 2011;14:537&#x2013;544. doi: 10.1016/j.cmet.2011.08.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2011.08.007</ArticleId><ArticleId IdType="pmc">PMC3190168</ArticleId><ArticleId IdType="pubmed">21982713</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamanaka R.B., Glasauer A., Hoover P., Yang S., Blatt H., Mullen A.R., Getsios S., Gottardi C.J., DeBerardinis R.J., Lavker R.M., et al. Mitochondrial reactive oxygen species promote epidermal differentiation and hair follicle development. Sci. Signal. 2013;6:ra8. doi: 10.1126/scisignal.2003638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2003638</ArticleId><ArticleId IdType="pmc">PMC4017376</ArticleId><ArticleId IdType="pubmed">23386745</ArticleId></ArticleIdList></Reference><Reference><Citation>Morimoto H., Iwata K., Ogonuki N., Inoue K., Atsuo O., Kanatsu-Shinohara M., Morimoto T., Yabe-Nishimura C., Shinohara T. ROS are required for mouse spermatogonial stem cell self- renewal. Cell Stem Cell. 2013;12:774&#x2013;786. doi: 10.1016/j.stem.2013.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.04.001</ArticleId><ArticleId IdType="pubmed">23746981</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas-Mendoza N., Morales-Gonz&#xe1;lez &#xc1;., Madrigal-Santill&#xe1;n E.O., Madrigal-Bujaidar E., &#xc1;lvarez-Gonz&#xe1;lez I., Garc&#xed;a-Melo L.F., Anguiano-Robledo L., Fregoso-Aguilar T., Morales-Gonzalez J.A. Antioxidant and Adaptative Response Mediated by Nrf2 during Physical Exercise. Antioxidants. 2019;8:196. doi: 10.3390/antiox8060196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox8060196</ArticleId><ArticleId IdType="pmc">PMC6617290</ArticleId><ArticleId IdType="pubmed">31242588</ArticleId></ArticleIdList></Reference><Reference><Citation>Brieger K., Schiavone S., Miller F.J., Jr., Krause K.H. Reactive oxygen species: From health to disease. Swiss Med. Wkly. 2012;142:w13659. doi: 10.4414/smw.2012.13659.</Citation><ArticleIdList><ArticleId IdType="doi">10.4414/smw.2012.13659</ArticleId><ArticleId IdType="pubmed">22903797</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;ppi M.G., Jaquet V., Belli D.C., Krause K.H. Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin. Immunopathol. 2008;30:255&#x2013;271. doi: 10.1007/s00281-008-0119-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-008-0119-2</ArticleId><ArticleId IdType="pubmed">18509648</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorce S., Krause K.H. NOX enzymes in the central nervous system: From signaling to disease. Antioxid. Redox Signal. 2009;11:2481&#x2013;2504. doi: 10.1089/ars.2009.2578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2009.2578</ArticleId><ArticleId IdType="pubmed">19309263</ArticleId></ArticleIdList></Reference><Reference><Citation>Pao M., Wiggs E.A., Anastacio M.M., Hyun J., DeCarlo E.S., Miller J.T., Anderson V.L., Malech H.L., Gallin J.I., Holland S.M. Cognitive function in patients with chronic granulomatous disease: A preliminary report. Psychosomatics. 2004;45:230&#x2013;234. doi: 10.1176/appi.psy.45.3.230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.psy.45.3.230</ArticleId><ArticleId IdType="pubmed">15123849</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson R.J., Jr., Gustafson K.E., Meghdadpour S., Harrell E.S., Johndrow D.A., Spock A. The role of biomedical and psychosocial processes in the intellectual and academic functioning of children and adolescents with cystic fibrosis. J. Clin. Psychol. 1992;48:3&#x2013;10. doi: 10.1002/1097-4679(199201)48:1&lt;3::AID-JCLP2270480102&gt;3.0.CO;2-H.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4679(199201)48:1&lt;3::AID-JCLP2270480102&gt;3.0.CO;2-H</ArticleId><ArticleId IdType="pubmed">1556213</ArticleId></ArticleIdList></Reference><Reference><Citation>Kishida K.T., Hoeffer C.A., Hu D., Pao M., Holland S.M., Klann E. Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease. Mol. Cell. Biol. 2006;26:5908&#x2013;5920. doi: 10.1128/MCB.00269-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00269-06</ArticleId><ArticleId IdType="pmc">PMC1592752</ArticleId><ArticleId IdType="pubmed">16847341</ArticleId></ArticleIdList></Reference><Reference><Citation>Ighodaro O.M., Akinloye O.A. First line defence antioxidants-superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPX): Their fundamental role in the entire antioxidant defence grid. Alex. J. Med. 2018;54:287&#x2013;293. doi: 10.1016/j.ajme.2017.09.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajme.2017.09.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal M.F. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 2002;32:797&#x2013;803. doi: 10.1016/S0891-5849(02)00780-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(02)00780-3</ArticleId><ArticleId IdType="pubmed">11978481</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenaz G., Bovina C., D&#x2019;Aurelio M., Fato R., Formiggini G., Genova M.L., Giuliano G., Pich M.M., Paolucci U.G.O., Castelli G.P., et al. Role of mitochondria in oxidative stress and ageing. Ann. N. Y. Acad. Sci. 2002;959:199&#x2013;213. doi: 10.1111/j.1749-6632.2002.tb02094.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2002.tb02094.x</ArticleId><ArticleId IdType="pubmed">11976197</ArticleId></ArticleIdList></Reference><Reference><Citation>Genova M.L., Pich M.M., Bernacchia A., Bianchi C., Biondi A., Bovina C., Falasca A.I., Formiggini G., Castelli G.P., Lenaz G. The mitochondrial production of reactive oxygen species in relation to aging and pathology. Ann. N. Y. Acad. Sci. 2004;1011:86&#x2013;100. doi: 10.1196/annals.1293.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1293.010</ArticleId><ArticleId IdType="pubmed">15126287</ArticleId></ArticleIdList></Reference><Reference><Citation>Dykens J.A. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated Ca2+ and Na+: Implications for neurodegeneration. J. Neurochem. 1994;63:584&#x2013;591. doi: 10.1046/j.1471-4159.1994.63020584.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1994.63020584.x</ArticleId><ArticleId IdType="pubmed">8035183</ArticleId></ArticleIdList></Reference><Reference><Citation>Carriedo S.G., Sensi S.L., Yin H.Z., Weiss J.H. AMPA exposures induce mitochondrial Ca2+ overload and ROS generation in spinal motor neurons in vitro. J. Neurosci. 2000;20:240&#x2013;250. doi: 10.1523/JNEUROSCI.20-01-00240.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-01-00240.2000</ArticleId><ArticleId IdType="pmc">PMC6774118</ArticleId><ArticleId IdType="pubmed">10627601</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell B. Oxidative stress and neurodegeneration: Where are we now? J. Neurochem. 2006;97:1634&#x2013;1658. doi: 10.1111/j.1471-4159.2006.03907.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03907.x</ArticleId><ArticleId IdType="pubmed">16805774</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliwell B. Role of free radicals in the neurodegenerative diseases: Therapeutic implications for antioxidant treatment. Drugs Aging. 2001;18:685&#x2013;716. doi: 10.2165/00002512-200118090-00004.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00002512-200118090-00004</ArticleId><ArticleId IdType="pubmed">11599635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrante R.J., Browne S.E., Shinobu L.A., Bowling A.C., Baik M.J., MacGarvey U., Kowall N.W., Brown R.H., Jr., Beal M.F. Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis. J. Neurochem. 1997;69:2064&#x2013;2074. doi: 10.1046/j.1471-4159.1997.69052064.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69052064.x</ArticleId><ArticleId IdType="pubmed">9349552</ArticleId></ArticleIdList></Reference><Reference><Citation>Abe K., Pan L.-H., Watanabe M., Kato T., Itoyama Y. Induction of nitrotyrosine-like immunoreactivity in the lower motor neuron of amyotrophic lateral sclerosis. Neurosci. Lett. 1995;199:152&#x2013;154. doi: 10.1016/0304-3940(95)12039-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(95)12039-7</ArticleId><ArticleId IdType="pubmed">8584246</ArticleId></ArticleIdList></Reference><Reference><Citation>Beal M.F., Ferrante R.J., Browne S.E., Matthews R.T., Kowall N.W., Brown R.H., Jr. Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neurol. 1997;42:644&#x2013;654. doi: 10.1002/ana.410420416.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410420416</ArticleId><ArticleId IdType="pubmed">9382477</ArticleId></ArticleIdList></Reference><Reference><Citation>Shaw P.J., Ince P.G., Falkous G., Mantle D. Oxidative damage to protein in sporadic motor neuron disease spinal cord. Ann. Neurol. 1995;38:691&#x2013;695. doi: 10.1002/ana.410380424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410380424</ArticleId><ArticleId IdType="pubmed">7574472</ArticleId></ArticleIdList></Reference><Reference><Citation>Cutler R.G., Pedersen W.A., Camandola S., Rothstein J.D., Mattson M.P. Evidence that accumulation of ceramides and cholesterol esters mediates oxidative stress-induced death of motor neurons in amyotrophic lateral sclerosis. Ann. Neurol. 2002;52:448&#x2013;457. doi: 10.1002/ana.10312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10312</ArticleId><ArticleId IdType="pubmed">12325074</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen W.A., Fu W., Keller J.N., Pedersen W.A., Fu W., Keller J.N., Markesbery W.R., Appel S., Smith R.G., Kasarskis E., et al. Protein modification by the lipid peroxidation product 4- hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann. Neurol. 1998;44:819&#x2013;824. doi: 10.1002/ana.410440518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440518</ArticleId><ArticleId IdType="pubmed">9818940</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson E.P., Henry Y.K., Henkel J.S., Smith R.G., Appel S.H. Increased lipid peroxidation in sera of ALS patients: A potential biomarker of disease burden. Neurology. 2004;62:1758&#x2013;1765. doi: 10.1212/WNL.62.10.1758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Volterra A., Trotti D., Tromba C., Floridi S., Racagni G. Glutamate uptake inhibition by oxygen free radicals in rat cortical astrocytes. J. Neurosci. 1994;14:2924&#x2013;2932. doi: 10.1523/JNEUROSCI.14-05-02924.1994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.14-05-02924.1994</ArticleId><ArticleId IdType="pmc">PMC6577465</ArticleId><ArticleId IdType="pubmed">7910203</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotti D., Rossi D., Gjesdal O., Levy L.M., Racagni G., Danbolt N.C., Volterra A. Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 1996;271:5976&#x2013;5979. doi: 10.1074/jbc.271.11.5976.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.11.5976</ArticleId><ArticleId IdType="pubmed">8626378</ArticleId></ArticleIdList></Reference><Reference><Citation>Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: A molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol. Sci. 1998;19:328&#x2013;334. doi: 10.1016/S0165-6147(98)01230-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-6147(98)01230-9</ArticleId><ArticleId IdType="pubmed">9745361</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S.D., Yin H.Z., Weiss J.H. Disruption of glial glutamate transport by reactive oxygen species produced in motor neurons. J. Neurosci. 2003;23:2627&#x2013;2633. doi: 10.1523/JNEUROSCI.23-07-02627.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-07-02627.2003</ArticleId><ArticleId IdType="pmc">PMC6742077</ArticleId><ArticleId IdType="pubmed">12684448</ArticleId></ArticleIdList></Reference><Reference><Citation>Heath P.R., Shaw P.J. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:438&#x2013;458. doi: 10.1002/mus.10186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10186</ArticleId><ArticleId IdType="pubmed">12362409</ArticleId></ArticleIdList></Reference><Reference><Citation>Spreux-Varoquaux O., Bensimon G., Lacomblez L., Salachas F., Pradat P.F., Le Forestier N., Marouan A., Dib M., Meininger V. Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: A reappraisal using a new HPLC method with coulometric detection in a large cohort of patients. J. Neurol. Sci. 2002;193:73&#x2013;78. doi: 10.1016/S0022-510X(01)00661-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-510X(01)00661-X</ArticleId><ArticleId IdType="pubmed">11790386</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao S.D., Weiss J.H. Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis. Trends Neurosci. 2004;27:17&#x2013;23. doi: 10.1016/j.tins.2003.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2003.11.001</ArticleId><ArticleId IdType="pubmed">14698606</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B.R., Shodis K.A., Lewis D.H., Rawling J.D., Sanjak M., Belden D.S., Hakim H., DeTan Y., Gaffney J.M. Natural history of amyotrophic lateral sclerosis: Quantification of symptoms, signs, strength, and Function. Adv. Neurol. 1995;68:163&#x2013;184.</Citation><ArticleIdList><ArticleId IdType="pubmed">8787228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A., Nakano I., Kurland L.T., Mulder D.W., Holley P.W., Saccomanno G. Fine structural study of neurofibrillary changes in a family with amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1984;43:471&#x2013;480. doi: 10.1097/00005072-198409000-00002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198409000-00002</ArticleId><ArticleId IdType="pubmed">6540800</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A.C., Donnenfeld H., Sasaki S., Nakano I. Fine structural observations of neurofilamentous changes in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 1984;43:461&#x2013;470. doi: 10.1097/00005072-198409000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198409000-00001</ArticleId><ArticleId IdType="pubmed">6540799</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., Tu P., Abtahian F., Trojanowski J.Q., Lee V.M. Neurofilaments and orthograde transport are reduced in ventral root axons of transgenic mice that express human SOD1 with a G93A mutation. J. Cell Biol. 1997;139:1307&#x2013;1315. doi: 10.1083/jcb.139.5.1307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.139.5.1307</ArticleId><ArticleId IdType="pmc">PMC2140205</ArticleId><ArticleId IdType="pubmed">9382875</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison B.M., Gordon J.W., Ripps M.E., Morrison J.H. Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: Neurochemical correlates of selective vulnerability. J. Comp. Neurol. 1996;373:619&#x2013;663. doi: 10.1002/(SICI)1096-9861(19960930)373:4&lt;619::AID-CNE9&gt;3.0.CO;2-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1096-9861(19960930)373:4&lt;619::AID-CNE9&gt;3.0.CO;2-4</ArticleId><ArticleId IdType="pubmed">8889947</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N.H., Jeong M.S., Choi S.Y., Kang J.H. Oxidative modification of neurofilament-L by the Cu,Zn-superoxide dismutase and hydrogen peroxide system. Biochimie. 2004;86:553&#x2013;559. doi: 10.1016/j.biochi.2004.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2004.07.006</ArticleId><ArticleId IdType="pubmed">15388232</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow J.P., Ye Y.Z., Strong M., Kang J.H. Superoxide dismutase catalyzes nitration of tyrosines by peroxynitrite in the rod and head domains of neurofilament-L. J. Neurochem. 1997;69:1945&#x2013;1953. doi: 10.1046/j.1471-4159.1997.69051945.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1997.69051945.x</ArticleId><ArticleId IdType="pubmed">9349539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingre C., Roos P.M., Piehl F., Kamel F., Fang F. Risk factors for amyotrophic lateral sclerosis. Clin. Epidemiol. 2015;7:181. doi: 10.2147/CLEP.S37505J.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP.S37505J</ArticleId><ArticleId IdType="pmc">PMC4334292</ArticleId><ArticleId IdType="pubmed">25709501</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Traynor B.J., Hardiman O., Chi&#xf2; A., Mitchell D., Swingler R.J., Millul A., Benn E., Beghi E. Incidence of amyotrophic lateral sclerosis in Europe. J. Neurol. Neurosurg. Psychiatry. 2010;81:385&#x2013;390. doi: 10.1136/jnnp.2009.183525.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2009.183525</ArticleId><ArticleId IdType="pmc">PMC2850819</ArticleId><ArticleId IdType="pubmed">19710046</ArticleId></ArticleIdList></Reference><Reference><Citation>Huisman M.H., de Jong S.W., van Doormaal P.T., Weinreich S.S., Schelhaas H.J., van der Kooi A.J., de Visser M., Veldink J.H., van den Berg L.H. Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology. J. Neurol. Neurosurg. Psychiatry. 2011;82:1165&#x2013;1170. doi: 10.1136/jnnp.2011.244939.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2011.244939</ArticleId><ArticleId IdType="pubmed">21622937</ArticleId></ArticleIdList></Reference><Reference><Citation>Piemonte and Valle d&#x2019;Aosta Register for Amyotrophic Lateral Sclerosis (PARALS) Incidence of ALS in Italy: Evidence for a uniform frequency in Western countries. Neurology. 2001;56:239&#x2013;244. doi: 10.1212/WNL.56.2.239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.56.2.239</ArticleId><ArticleId IdType="pubmed">11160962</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., Van Swieten J.C., Myllykangas L., et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256. doi: 10.1016/j.neuron.2011.09.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.011</ArticleId><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gijselinck I., Van Langenhove T., van der Zee J., Sleegers K., Philtjens S., Kleinberger G., Janssens J., Bettens K., Van Cauwenberghe C., Pereson S., et al. A C9orf72 promoter repeat expansion in a Flanders-Belgian cohort with disorders of the frontotemporal lobar degeneration-amyotrophic lateral sclerosis spectrum: A gene identification study [published correction appears in Lancet Neurol. 2012 Feb;11:125] Lancet Neurol. 2012;11:54&#x2013;65. doi: 10.1016/S1474-4422(11)70261-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70261-7</ArticleId><ArticleId IdType="pubmed">22154785</ArticleId></ArticleIdList></Reference><Reference><Citation>Belzil V.V., Bauer P.O., Prudencio M., Gendron T.F., Stetler C.T., Yan I.K., Pregent L., Daughrity L., Baker M.C., Rademakers R., et al. Reduced C9orf72 gene expression in c9FTD/ALS is caused by histone trimethylation, an epigenetic event detectable in blood. Acta Neuropathol. 2013;126:895&#x2013;905. doi: 10.1007/s00401-013-1199-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1199-1</ArticleId><ArticleId IdType="pmc">PMC3830740</ArticleId><ArticleId IdType="pubmed">24166615</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Rothstein J.D. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat. Rev. Neurosci. 2016;17:383. doi: 10.1038/nrn.2016.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2016.38</ArticleId><ArticleId IdType="pmc">PMC7376590</ArticleId><ArticleId IdType="pubmed">27150398</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., et al. Poly(GR) in C9ORF72-Related ALS/FTD Compromises Mitochondrial Function and Increases Oxidative Stress and DNA Damage in iPSC-Derived Motor Neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Rademakers R., Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurol. 2010;9:995&#x2013;1007. doi: 10.1016/S1474-4422(10)70195-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70195-2</ArticleId><ArticleId IdType="pubmed">20864052</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Velde C.V., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008;40:572&#x2013;574. doi: 10.1038/ng.132.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.132</ArticleId><ArticleId IdType="pubmed">18372902</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin V.M., Leverenz J.B., Bekris L.M., Bird T.D., Yuan W., Elman L.B., Clay D., Wood E.M., Chen-Plotkin A.S., Martinez-Lage M., et al. TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: A genetic and histopathological analysis. Lancet Neurol. 2008;7:409&#x2013;416. doi: 10.1016/S1474-4422(08)70071-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70071-1</ArticleId><ArticleId IdType="pmc">PMC3546119</ArticleId><ArticleId IdType="pubmed">18396105</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford N.J., Zhang Y.-J., Baker M., Gass J.M., Finch N.A., Xu Y.-F., Stewart H., Kelley B.J., Kuntz K., Crook R.J.P., et al. Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis. PLoS Genet. 2008;4:e1000193. doi: 10.1371/journal.pgen.1000193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1000193</ArticleId><ArticleId IdType="pmc">PMC2527686</ArticleId><ArticleId IdType="pubmed">18802454</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>McAleese K.E., Walker L., Erskine D., Thomas A.J., McKeith I.G., Attems J. TDP-43 pathology in Alzheimer&#x2019;s disease, dementia with Lewy bodies and ageing. Brain Pathol. 2017:472&#x2013;479. doi: 10.1111/bpa.12424.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12424</ArticleId><ArticleId IdType="pmc">PMC8029292</ArticleId><ArticleId IdType="pubmed">27495267</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordana M.T., Piccinini M., Grifoni S., De Marco G., Vercellino M., Magistrello M., Pellerino A., Buccinn&#xe0; B., Lupino E., Rinaudo M.T. TDP-43 Redistribution is an Early Event in Sporadic Amyotrophic Lateral Sclerosis. Brain Pathol. 2010;20:351&#x2013;360. doi: 10.1111/j.1750-3639.2009.00284.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1750-3639.2009.00284.x</ArticleId><ArticleId IdType="pmc">PMC8094784</ArticleId><ArticleId IdType="pubmed">19338576</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejzini R., Flynn L.L., Pitout I.L., Fletcher S., Wilton S.D., Akkari P.A. ALS Genetics, Mechanisms, and Therapeutics: Where Are We Now? Front. Neurosci. 2019;13:1310. doi: 10.3389/fnins.2019.01310.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01310</ArticleId><ArticleId IdType="pmc">PMC6909825</ArticleId><ArticleId IdType="pubmed">31866818</ArticleId></ArticleIdList></Reference><Reference><Citation>Iguchi Y., Katsuno M., Takagi S., Ishigaki S., Niwa J.-I., Hasegawa M., Tanaka F., Sobue G. Oxidative stress induced by glutathione depletion reproduces pathological modifications of TDP-43 linked to TDP-43 proteinopathies. Neurobiol. Dis. 2012;45:862&#x2013;870. doi: 10.1016/j.nbd.2011.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.12.002</ArticleId><ArticleId IdType="pubmed">22198567</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang P., Deng J., Dong J., Liu J., Bigio E.H., Mesulam M., Wang T., Sun L., Wang L., Lee A.Y.-L., et al. TDP-43 induces mitochondrial damage and activates the mitochondrial unfolded protein response. PLoS Genet. 2019;15:e1007947. doi: 10.1371/journal.pgen.1007947.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1007947</ArticleId><ArticleId IdType="pmc">PMC6524796</ArticleId><ArticleId IdType="pubmed">31100073</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou Z.-Y., Cui L.-Y., Sun Q., Li X.-G., Liu M.-S., Xu Y., Zhou Y., Yang X.-Z. De novo FUS gene mutations are associated with juvenile-onset sporadic amyotrophic lateral sclerosis in China. Neurobiol. Aging. 2013;34:1312.e1&#x2013;1312.e8. doi: 10.1016/j.neurobiolaging.2012.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.09.005</ArticleId><ArticleId IdType="pubmed">23046859</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A., Buratti E. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins. J. Neurochem. 2016;138(Suppl. 1):95&#x2013;111. doi: 10.1111/jnc.13625.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13625</ArticleId><ArticleId IdType="pubmed">27015757</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Guo W., Mitra J., Hegde P.M., Vandoorne T., Eckelmann B.J., Mitra S., Tomkinson A.E., Bosch L.V.D., Hegde M.L. Mutant FUS causes DNA ligation defects to inhibit oxidative damage repair in Amyotrophic Lateral Sclerosis. Nat. Commun. 2018;9:3683. doi: 10.1038/s41467-018-06111-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-06111-6</ArticleId><ArticleId IdType="pmc">PMC6134028</ArticleId><ArticleId IdType="pubmed">30206235</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer F., Am&#xe9; J.C., Schreiber V., Nakamura J., M&#xe9;nissier-de Murcia J., de Murcia G. Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair. Methods Enzymol. 2006;409:493&#x2013;510. doi: 10.1016/S0076-6879(05)09029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0076-6879(05)09029</ArticleId><ArticleId IdType="pubmed">16793420</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani R.S., Karimi-Busheri F., Fanta M., Caldecott K.W., Cass C.E., Weinfeld M. Biophysical characterization of human XRCC1 and its binding to damaged and undamaged DNA. Biochemistry. 2004;43:16505&#x2013;16514. doi: 10.1021/bi048615m.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi048615m</ArticleId><ArticleId IdType="pubmed">15610045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan L., Nakajima S., Oohata Y., Takao M., Okano S., Masutani M., Wilson S.H., Yasui A. In situ analysis of repair processes for oxidative DNA damage in mammalian cells. Proc. Natl. Acad. Sci. USA. 2004;101:13738&#x2013;13743. doi: 10.1073/pnas.0406048101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0406048101</ArticleId><ArticleId IdType="pmc">PMC518826</ArticleId><ArticleId IdType="pubmed">15365186</ArticleId></ArticleIdList></Reference><Reference><Citation>Mani R.S., Fanta M., Karimi-Busheri F., Silver E., Virgen C.A., Caldecott K.W., Cass C.E., Weinfeld M. XRCC1 stimulates polynucleotide kinase by enhancing its damage discrimination and displacement from DNA repair intermediates. J. Biol. Chem. 2007;282:28004&#x2013;28013. doi: 10.1074/jbc.M704867200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M704867200</ArticleId><ArticleId IdType="pubmed">17650498</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortini P., Pascucci B., Parlanti E., D&#x2019;errico M., Simonelli V., Dogliotti E. The base excision repair: Mechanisms and its relevance for cancer susceptibility. Biochemie. 2003;85:1053&#x2013;1071. doi: 10.1016/j.biochi.2003.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2003.11.003</ArticleId><ArticleId IdType="pubmed">14726013</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo F., Mirra A., Carr&#xec; M.T. Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives. Neurosci. Lett. 2017;636:3&#x2013;8. doi: 10.1016/j.neulet.2016.04.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.04.065</ArticleId><ArticleId IdType="pubmed">27150074</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen T.J., Hwang A.W., Restrepo C.R., Yuan C.X., Trojanowski J.Q., Lee V.M. An acetylation switch controls TDP-43 function and aggregation propensity. Nat. Commun. 2015;6:5845. doi: 10.1038/ncomms6845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6845</ArticleId><ArticleId IdType="pmc">PMC4407365</ArticleId><ArticleId IdType="pubmed">25556531</ArticleId></ArticleIdList></Reference><Reference><Citation>Vance C., Scotter E.L., Nishimura A.L., Troakes C., Mitchell J.C., Kathe C., Urwin H., Manser C., Miller C.C., Hortob&#xe1;gyi T., et al. ALS mutant FUS disrupts nuclear localization and sequesters wild- type FUS within cytoplasmic stress granules. Hum. Mol. Genet. 2013;22:2676&#x2013;2688. doi: 10.1093/hmg/ddt117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt117</ArticleId><ArticleId IdType="pmc">PMC3674807</ArticleId><ArticleId IdType="pubmed">23474818</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y.R., King O.D., Shorter J., Gitler A.D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013;201:361&#x2013;372. doi: 10.1083/jcb.201302044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201302044</ArticleId><ArticleId IdType="pmc">PMC3639398</ArticleId><ArticleId IdType="pubmed">23629963</ArticleId></ArticleIdList></Reference><Reference><Citation>Parker S.J., Meyerowitz J., James J.L., Liddell J.R., Crouch P.J., Kanninen K.M., White A.R. Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates. Neurochem. Int. 2012;60:415&#x2013;424. doi: 10.1016/j.neuint.2012.01.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2012.01.019</ArticleId><ArticleId IdType="pubmed">22306778</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferber E.C., Peck B., Delpuech O., Bell G., East P., Schulze A. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression. Cell Death Differ. 2012;19:968&#x2013;979. doi: 10.1038/cdd.2011.179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2011.179</ArticleId><ArticleId IdType="pmc">PMC3354049</ArticleId><ArticleId IdType="pubmed">22139133</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Baldie G., Periz G.J. WangRNA-processing protein TDP-43 regulates FOXO-dependent protein quality control in stress response. PLoS Genet. 2014;10:e1004693. doi: 10.1371/journal.pgen.1004693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004693</ArticleId><ArticleId IdType="pmc">PMC4199500</ArticleId><ArticleId IdType="pubmed">25329970</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez-Ramos C., Tierrez A., Fabregat-Andr&#xe9;s O., Wild B., S&#xe1;nchez-Cabo F., Arduini A., Dopazo A., Monsalve M. PGC-1&#x3b1; regulates translocated in liposarcoma activity: Role in oxidative stress gene expression. Antioxid. Redox Signal. 2011;15:325&#x2013;337. doi: 10.1089/ars.2010.3643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2010.3643</ArticleId><ArticleId IdType="pubmed">21338289</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisskopf M.G., McCullough M.L., Calle E.E., Thun M.J., Cudkowicz M., Ascherio A. Prospective study of cigarette smoking and amyotrophic lateral sclerosis. Am. J. Epidemiol. 2004;160:26&#x2013;33. doi: 10.1093/aje/kwh179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/aje/kwh179</ArticleId><ArticleId IdType="pubmed">15229114</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V., Bueno-De-Mesquita H.B., Vermeulen R., Andersen P.M., Kyrozis A., Linseisen J., Kaaks R., Allen N.E., Roddam A.W., Boshuizen H.C., et al. Smoking and risk for amyotrophic lateral sclerosis: Analysis of the EPIC cohort. Ann. Neurol. 2009;65:378&#x2013;385. doi: 10.1002/ana.21653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21653</ArticleId><ArticleId IdType="pubmed">19399866</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., Bellocco R., Hern&#xe1;n M.A., Ye W. Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis&#x2014;A prospective cohort study. Neuroepidemiology. 2006;27:217&#x2013;221. doi: 10.1159/000096956.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000096956</ArticleId><ArticleId IdType="pubmed">17106211</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanbaeva D.G., Dentener M.A., Creutzberg E.C., Wesseling G., Wouters E.F.M. Systemic Effects of Smoking. Chest. 2007;131:1557&#x2013;1566. doi: 10.1378/chest.06-2179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.06-2179</ArticleId><ArticleId IdType="pubmed">17494805</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiziler A.R., Aydemir B., Onaran I., Alici B., Ozkara H., Gulyasar T., Akyolcu M.C. High Levels of Cadmium and Lead in Seminal Fluid and Blood of Smoking Men are Associated with High Oxidative Stress and Damage in Infertile Subjects. Biol. Trace Element Res. 2007;120:82&#x2013;91. doi: 10.1007/s12011-007-8020-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12011-007-8020-8</ArticleId><ArticleId IdType="pubmed">17916958</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico E., Factor-Litvak P., Santella R.M., Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2013;65:509&#x2013;527. doi: 10.1016/j.freeradbiomed.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallo V., Wark P.A., Jenab M., Pearce N., Brayne C., Vermeulen R., Andersen P.M., Hallmans G., Kyrozis A., Vanacore N., et al. Prediagnostic body fat and risk of death from amyotrophic lateral sclerosis: The EPIC cohort. Neurology. 2013;80:829&#x2013;838. doi: 10.1212/WNL.0b013e3182840689.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182840689</ArticleId><ArticleId IdType="pmc">PMC3598455</ArticleId><ArticleId IdType="pubmed">23390184</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Reilly &#xc9;.J., Wang H., Weisskopf M.G., Fitzgerald K.C., Falcone G., McCullough M.L., Thun M., Park Y., Kolonel L.N., Ascherio A. Premorbid body mass index and risk of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2012;14:205&#x2013;211. doi: 10.3109/21678421.2012.735240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.735240</ArticleId><ArticleId IdType="pmc">PMC3615420</ArticleId><ArticleId IdType="pubmed">23134505</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A., Benzi G., Dossena M., Mutani R., Mora G. Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players. Brain. 2005;128:472&#x2013;476. doi: 10.1093/brain/awh373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh373</ArticleId><ArticleId IdType="pubmed">15634730</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel E.L. Football increases the risk for Lou Gehrig&#x2019;s disease, amyotrophic lateral sclerosis. Percept. Mot. Skills. 2007;104:1251&#x2013;1254. doi: 10.2466/pms.104.4.1251-1254.</Citation><ArticleIdList><ArticleId IdType="doi">10.2466/pms.104.4.1251-1254</ArticleId><ArticleId IdType="pubmed">17879657</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Calvo A., Dossena M., Ghiglione P., Mutani R., Mora G. ALS in Italian professional soccer players: The risk is still present and could be soccer-specific. Amyotroph. Lateral Scler. 2009;10:205&#x2013;209. doi: 10.1080/17482960902721634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960902721634</ArticleId><ArticleId IdType="pubmed">19267274</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.S., Huang Y.H. Effects of exercise intensity on lymphocyte apoptosis induced by oxidative stress in men. Eur. J. Appl. Physiol. 2005;95:290. doi: 10.1007/s00421-005-0005-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-005-0005-8</ArticleId><ArticleId IdType="pubmed">16096840</ArticleId></ArticleIdList></Reference><Reference><Citation>Reid M.B. Free radicals and muscle fatigue: Of ROS, canaries, and the IOC. Free Radic. Biol. Med. 2008;44:169&#x2013;179. doi: 10.1016/j.freeradbiomed.2007.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2007.03.002</ArticleId><ArticleId IdType="pubmed">18191753</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole K., Perez-Polo J.R. Neuronal trauma model: In search of Thanatos. Int. J. Dev. Neurosci. 2004;22:485&#x2013;496. doi: 10.1016/j.ijdevneu.2004.07.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijdevneu.2004.07.015</ArticleId><ArticleId IdType="pubmed">15465278</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Leigh P.N. Trouble on the pitch: Are professional football players at increased risk of developing amyotrophic lateral sclerosis? Brain. 2005;128:451&#x2013;453. doi: 10.1093/brain/awh426.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh426</ArticleId><ArticleId IdType="pubmed">15713848</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F., Umbach D.M., Lehman T.A., Park L.P., Munsat T.L., Shefner J.M., Sandler D.P., Hu H., Taylor J.A. Amyotrophic lateral sclerosis, lead, and genetic susceptibility: Polymorphisms in the delta-aminolevulinic acid dehydratase and vitamin D receptor genes. Environ. Health Perspect. 2003;111:1335&#x2013;1339. doi: 10.1289/ehp.6109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.6109</ArticleId><ArticleId IdType="pmc">PMC1241615</ArticleId><ArticleId IdType="pubmed">12896855</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F., Umbach D.M., Munsat T.L., Shefner J.M., Hu H., Sandler D.P. Lead Exposure and Amyotrophic Lateral Sclerosis. Epidemiology. 2002;13:311&#x2013;319. doi: 10.1097/00001648-200205000-00012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001648-200205000-00012</ArticleId><ArticleId IdType="pubmed">11964933</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu H., Payton M., Kornc S., Aro A., Sparrow D., Weiss S.T., Rotnitzky A. Determinants of Bone and Blood Lead Levels among Community-exposed Middle-aged to Elderly Men: The Normative Aging Study. Am. J. Epidemiol. 1996;144:749&#x2013;759. doi: 10.1093/oxfordjournals.aje.a008999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a008999</ArticleId><ArticleId IdType="pubmed">8857824</ArticleId></ArticleIdList></Reference><Reference><Citation>Chetty C.S., Vemuri M.C., Campbell K., Suresh C. Lead-induced cell death of human neuroblastoma cells involves GSH dep-rivation. Cell. Mol. Biol. Lett. 2005;10:413&#x2013;423.</Citation><ArticleIdList><ArticleId IdType="pubmed">16217553</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito A.G., Martinez-Palma L., Vargas M.R., Pehar M., Ma&#xf1;ay N., Beckman J.S., Barbeito L., Cassina P. Lead exposure stimulates VEGF expression in the spinal cord and extends survival in a mouse model of ALS. Neurobiol. Dis. 2010;37:574&#x2013;580. doi: 10.1016/j.nbd.2009.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2009.11.007</ArticleId><ArticleId IdType="pmc">PMC2824063</ArticleId><ArticleId IdType="pubmed">19914377</ArticleId></ArticleIdList></Reference><Reference><Citation>Farina M., Avila D.S., da Rocha J.B., Aschner M. Metals, oxidative stress and neurodegeneration: A focus on iron, manganese and mercury. Neurochem. Int. 2013;62:575&#x2013;594. doi: 10.1016/j.neuint.2012.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2012.12.006</ArticleId><ArticleId IdType="pmc">PMC3615063</ArticleId><ArticleId IdType="pubmed">23266600</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson A.W., Erikson K.M., Aschner M. Manganese neurotoxicity. Ann. N. Y. Acad. Sci. 2004;1012:115&#x2013;128. doi: 10.1196/annals.1306.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1306.009</ArticleId><ArticleId IdType="pubmed">15105259</ArticleId></ArticleIdList></Reference><Reference><Citation>Sjogren B., Iregren A., Frech W., Hagman M., Johansson L., Tesarz M., Wennberg A. Effects on the nervous system among welders exposed to aluminium and manganese. Occup. Environ. Med. 1996;53:32&#x2013;40. doi: 10.1136/oem.53.1.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/oem.53.1.32</ArticleId><ArticleId IdType="pmc">PMC1128401</ArticleId><ArticleId IdType="pubmed">8563855</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellingsen D.G., Konstantinov R., Bast-Pettersen R., Merkurjeva L., Chashchin M., Thomassen Y., Chashchin V. A neurobehavioral study of current and former welders exposed to manganese. NeuroToxicology. 2008;29:48&#x2013;59. doi: 10.1016/j.neuro.2007.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2007.08.014</ArticleId><ArticleId IdType="pubmed">17942157</ArticleId></ArticleIdList></Reference><Reference><Citation>Dusek P., Roos P.M., Litwin T., Schneider S.A., Flaten T.P., Aaseth J. The neurotoxicity of iron, copper and manganese in Parkinson&#x2019;s and Wilson&#x2019;s diseases. J. Trace Elements Med. Biol. 2015;31:193&#x2013;203. doi: 10.1016/j.jtemb.2014.05.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jtemb.2014.05.007</ArticleId><ArticleId IdType="pubmed">24954801</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasarskis E.J., Tandon L., Lovell M.A., Ehmann W.D. Aluminum, calcium, and iron in the spinal cord of patients with sporadic amyotrophic lateral sclerosis using laser microprobe mass spectroscopy: A preliminary study. J. Neurol. Sci. 1995;130:203&#x2013;208. doi: 10.1016/0022-510X(95)00037-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(95)00037-3</ArticleId><ArticleId IdType="pubmed">8586987</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwan J.Y., Jeong S.Y., Van Gelderen P., Deng H.X., Quezado M.M., Danielian L.E., Butman J.A., Chen L., Bayat E., Russell J., et al. Iron accumulation in deep cortical layers accounts for MRI signal abnormali-ties in ALS: Correlating 7 tesla MRI and pathology. PLoS ONE. 2012;7:e35241. doi: 10.1371/journal.pone.0035241.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0035241</ArticleId><ArticleId IdType="pmc">PMC3328441</ArticleId><ArticleId IdType="pubmed">22529995</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamel F., Umbach D.M., Bedlack R.S., Richards M., Watson M., Alavanja M.C., Blair A., Hoppin J.A., Schmidt S., Sandler D.P. Pesticide exposure and amyotrophic lateral sclerosis. NeuroToxicology. 2012;33:457&#x2013;462. doi: 10.1016/j.neuro.2012.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuro.2012.04.001</ArticleId><ArticleId IdType="pmc">PMC3358481</ArticleId><ArticleId IdType="pubmed">22521219</ArticleId></ArticleIdList></Reference><Reference><Citation>Malek A.M., Barchowsky A., Bowser R., Youk A., Talbott E.O. Pesticide exposure as a risk factor for amyotrophic lateral sclerosis: A meta-analysis of epidemiological studies. Environ. Res. 2012;117:112&#x2013;119. doi: 10.1016/j.envres.2012.06.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.envres.2012.06.007</ArticleId><ArticleId IdType="pubmed">22819005</ArticleId></ArticleIdList></Reference><Reference><Citation>Soltaninejad K., Abdollahi M. Current opinion on the science of organophosphate pesticides and toxic stress: A systematic review. Med. Sci. Monit. 2009;15:RA75&#x2013;RA90.</Citation><ArticleIdList><ArticleId IdType="pubmed">19247260</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmuck G., Rohrdanz E., Tran-Thi Q.H., Kahl R., Schluter G. Oxidative stress in rat cortical neurons and astrocytes induced by paraquat in vitro. Neurotox. Res. 2002;4:1&#x2013;13. doi: 10.1080/10298420290007574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10298420290007574</ArticleId><ArticleId IdType="pubmed">12826488</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa L.G. Current issues in organophosphate toxicology. Clin. Chim. Acta. 2006;366:1&#x2013;13. doi: 10.1016/j.cca.2005.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cca.2005.10.008</ArticleId><ArticleId IdType="pubmed">16337171</ArticleId></ArticleIdList></Reference><Reference><Citation>Mu&#xf1;iz J.F., McCauley L., Scherer J., Lasarev M.R., Koshy M., Kow Y., Nazar-Stewart V., Kisby G. Biomarkers of oxidative stress and DNA damage in agricultural workers: A pilot study. Toxicol. Appl. Pharmacol. 2008;227:97&#x2013;107. doi: 10.1016/j.taap.2007.10.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.taap.2007.10.027</ArticleId><ArticleId IdType="pubmed">18086483</ArticleId></ArticleIdList></Reference><Reference><Citation>Suntres Z.E. Role of antioxidants in paraquat toxicity. Toxicology. 2002;180:65&#x2013;77. doi: 10.1016/S0300-483X(02)00382-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0300-483X(02)00382-7</ArticleId><ArticleId IdType="pubmed">12324200</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutheil F., Beaune P., Loriot M.A. Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cyto-chrome P450 enzymes in normal and pathological human brain. Biochimie. 2008;90:426&#x2013;436. doi: 10.1016/j.biochi.2007.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2007.10.007</ArticleId><ArticleId IdType="pubmed">17997991</ArticleId></ArticleIdList></Reference><Reference><Citation>Day B.J., Patel M., Calavetta L., Chang L.-Y., Stamler J.S. A mechanism of paraquat toxicity involving nitric oxide synthase. Proc. Natl. Acad. Sci. USA. 1999;96:12760&#x2013;12765. doi: 10.1073/pnas.96.22.12760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.22.12760</ArticleId><ArticleId IdType="pmc">PMC23088</ArticleId><ArticleId IdType="pubmed">10535996</ArticleId></ArticleIdList></Reference><Reference><Citation>Purisai M.G., McCormack A.L., Cumine S., Li J., Isla M.Z., Di Monte D.A. Microglial activation as a priming event leading to paraquat-induced dopaminergic cell degeneration. Neurobiol. Dis. 2007;25:392&#x2013;400. doi: 10.1016/j.nbd.2006.10.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.10.008</ArticleId><ArticleId IdType="pmc">PMC2001246</ArticleId><ArticleId IdType="pubmed">17166727</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X.-F., Block M.L., Zhang W., Qin L., Wilson B., Zhang W.-Q., Veronesi B., Hong J.-S. The Role of Microglia in Paraquat-Induced Dopaminergic Neurotoxicity. Antioxid. Redox Signal. 2005;7:654&#x2013;661. doi: 10.1089/ars.2005.7.654.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2005.7.654</ArticleId><ArticleId IdType="pubmed">15890010</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S., Hwang J., Lee W.H., Hwang D.Y., Suk K. Role of protein kinase Cdelta in paraquat-induced glial cell death. J. Neurosci. Res. 2008;86:2062&#x2013;2070. doi: 10.1002/jnr.21643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.21643</ArticleId><ArticleId IdType="pubmed">18335519</ArticleId></ArticleIdList></Reference><Reference><Citation>Cocheme H.M., Murphy M.P. Complex I is the major site of mitochondrial superoxide production by paraquat. J. Biol. Chem. 2008;283:1786&#x2013;1798. doi: 10.1074/jbc.M708597200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M708597200</ArticleId><ArticleId IdType="pubmed">18039652</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi W.S., Kruse S.E., Palmiter R.D., Xia Z. Mitochondrial complex I inhibition is not required for dopaminergicneuron death induced by rotenone, MPP(+), or paraquat. Proc. Natl. Acad. Sci. USA. 2008;105:15136&#x2013;15141. doi: 10.1073/pnas.0807581105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0807581105</ArticleId><ArticleId IdType="pmc">PMC2567505</ArticleId><ArticleId IdType="pubmed">18812510</ArticleId></ArticleIdList></Reference><Reference><Citation>Roos P.M., Vesterberg O., Nordberg M. Metals in Motor Neuron Diseases. Exp. Biol. Med. 2006;231:1481&#x2013;1487. doi: 10.1177/153537020623100906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/153537020623100906</ArticleId><ArticleId IdType="pubmed">17018870</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutedja N.A., Fischer K., Veldink J.H., Van Der Heijden G.J., Kromhout H., Heederik D., Huisman M.H., Wokke J.J., Berg L.H.V.D. What we truly know about occupation as a risk factor for ALS: A critical and systematic review. Amyotroph. Lateral Scler. 2009;10:295&#x2013;301. doi: 10.3109/17482960802430799.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960802430799</ArticleId><ArticleId IdType="pubmed">19922116</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang F., Quinlan P., Ye W., Barber M.K., Umbach D.M., Sandler D.P., Kamel F. Workplace Exposures and the Risk of Amyotrophic Lateral Sclerosis. Environ. Health Perspect. 2009;117:1387&#x2013;1392. doi: 10.1289/ehp.0900580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.0900580</ArticleId><ArticleId IdType="pmc">PMC2737014</ArticleId><ArticleId IdType="pubmed">19750102</ArticleId></ArticleIdList></Reference><Reference><Citation>Xi Z., Yunusova Y., Van Blitterswijk M., Dib S., Ghani M., Moreno D., Sato C., Liang Y., Singleton A., Robertson J., et al. Identical twins with the C9orf72 repeat expansion are discordant for ALS. Neurology. 2014;83:1476&#x2013;1478. doi: 10.1212/WNL.0000000000000886.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000000886</ArticleId><ArticleId IdType="pmc">PMC4206161</ArticleId><ArticleId IdType="pubmed">25209579</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill S.S., Tuteja N. Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants. Plant Physiol. Biochem. 2010;48:909&#x2013;930. doi: 10.1016/j.plaphy.2010.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plaphy.2010.08.016</ArticleId><ArticleId IdType="pubmed">20870416</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuppanapandian T., Moon J.C., Kim C., Manoharan K., Kim W. Reactive oxygen species in plants: Their generation, signal transduction, and scavenging mechanisms. Aust. J. Crop Sci. 2011;5:709.</Citation></Reference><Reference><Citation>Fetherolf M.M., Boyd S.D., Winkler D.D., Winge D.R. Oxygen-dependent activation of Cu,Zn-superoxide dismutase-1. Metallomics. 2017;9:1047&#x2013;1059. doi: 10.1039/C6MT00298F.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6MT00298F</ArticleId><ArticleId IdType="pubmed">28686251</ArticleId></ArticleIdList></Reference><Reference><Citation>Luchinat E., Barbieri L., Rubino J.T., Kozyreva T., Cantini F., Banci L. In-cell NMR reveals potential precursor of toxic species from SOD1 fALS mutants. Nat. Commun. 2014;5:5502. doi: 10.1038/ncomms6502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms6502</ArticleId><ArticleId IdType="pubmed">25429517</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitch J.M., Yick P.J., Culotta V.C. The Right to Choose: Multiple Pathways for Activating Copper, Zinc Superoxide Dismutase. J. Biol. Chem. 2009;284:24679&#x2013;24683. doi: 10.1074/jbc.R109.040410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R109.040410</ArticleId><ArticleId IdType="pmc">PMC2757171</ArticleId><ArticleId IdType="pubmed">19586921</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamb A.L., Wernimont A.K., Pfahl R.A., O&#x2019;Halloran T.V., Rosenzweig A.C. Crystal Structure of the Second Domain of the Human Copper Chaperone for Superoxide Dismutase. Biochemistry. 2000;39:1589&#x2013;1595. doi: 10.1021/bi992822i.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi992822i</ArticleId><ArticleId IdType="pubmed">10677207</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenzweig A. Structure and chemistry of the copper chaperone proteins. Curr. Opin. Chem. Biol. 2000;4:140&#x2013;147. doi: 10.1016/S1367-5931(99)00066-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1367-5931(99)00066-6</ArticleId><ArticleId IdType="pubmed">10742187</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., O&#x2019;Halloran T.V. Posttranslational Modifications in Cu,Zn-Superoxide Dismutase and Mutations Associated with Amyotrophic Lateral Sclerosis. Antioxid. Redox Signal. 2006;8:847&#x2013;867. doi: 10.1089/ars.2006.8.847.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2006.8.847</ArticleId><ArticleId IdType="pmc">PMC1633719</ArticleId><ArticleId IdType="pubmed">16771675</ArticleId></ArticleIdList></Reference><Reference><Citation>Racek J. Superoxiddismut&#xe1;za.  [(accessed on 18 February 2017)]; Available online:  www.krevnicentrum.cz/laboratorni-prirucka/BOJRAAI.htm.</Citation></Reference><Reference><Citation>Valentine J.S., Doucette P.A., Zittin Potter S. Copper-zinc superoxide dismutase and amyotrophic lateral sclerosis. Annu. Rev. Biochem. 2005;74:563&#x2013;593. doi: 10.1146/annurev.biochem.72.121801.161647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.biochem.72.121801.161647</ArticleId><ArticleId IdType="pubmed">15952898</ArticleId></ArticleIdList></Reference><Reference><Citation>Leinartaite L., Saraboji K., Nordlund A., Logan D.T., Oliveberg M. Folding Catalysis by Transient Coordination of Zn2+ to the Cu Ligands of the ALS-Associated Enzyme Cu/Zn Superoxide Dismutase 1. J. Am. Chem. Soc. 2010;132:13495&#x2013;13504. doi: 10.1021/ja1057136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja1057136</ArticleId><ArticleId IdType="pubmed">20822138</ArticleId></ArticleIdList></Reference><Reference><Citation>Banci L., Bertini I., Cantini F., Kozyreva T., Massagni C., Palumaa P., Rubino J.T., Zovo K. Human superoxide dismutase 1 (hSOD1) maturation through interactiowith human copper chaperone for SOD1 (hCCS) Proc. Natl. Acad. Sci. USA. 2012;109:13555&#x2013;13560. doi: 10.1073/pnas.1207493109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1207493109</ArticleId><ArticleId IdType="pmc">PMC3427097</ArticleId><ArticleId IdType="pubmed">22869735</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong P.C., Waggoner D., Subramaniam J.R., Tessarollo L., Bartnikas T.B., Culotta V.C., Price D.L., Rothstein J., Gitlin J.D. Copper chaperone for superoxide dismutase is essential to activate mammalian Cu/Zn superoxide dismutase. Proc. Natl. Acad. Sci. USA. 2000;97:2886&#x2013;2891. doi: 10.1073/pnas.040461197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.040461197</ArticleId><ArticleId IdType="pmc">PMC16025</ArticleId><ArticleId IdType="pubmed">10694572</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa Y., Torres A.S., O&#x2019;Halloran T.V. Oxygen-induced maturation of SOD1: A key role for disulfide formation by the copper chaperone CCS. EMBO J. 2004;23:2872&#x2013;2881. doi: 10.1038/sj.emboj.7600276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600276</ArticleId><ArticleId IdType="pmc">PMC1150991</ArticleId><ArticleId IdType="pubmed">15215895</ArticleId></ArticleIdList></Reference><Reference><Citation>Fetherolf M.M., Boyd S.D., Taylor A.B., Kim H.J., Wohlschlegel J.A., Blackburn N.J., Hart P.J., Winge D.R., Winkler D.D. Copper-zinc superoxide dismutase is activated through a sulfenic acid intermediate at a copper ion entry site. J. Biol. Chem. 2017;292:12025&#x2013;12040. doi: 10.1074/jbc.M117.775981.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M117.775981</ArticleId><ArticleId IdType="pmc">PMC5519355</ArticleId><ArticleId IdType="pubmed">28533431</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd S.D., Calvo J.S., Liu L., Ullrich M.S., Skopp A., Meloni G., Winkler D.D. The yeast copper chaperone for copper-zinc superoxide dismutase (CCS1) is a multifunctional chaperone promoting all levels of SOD1 maturation. J. Biol. Chem. 2019;294:1956&#x2013;1966. doi: 10.1074/jbc.RA118.005283.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.005283</ArticleId><ArticleId IdType="pmc">PMC6369272</ArticleId><ArticleId IdType="pubmed">30530491</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyd S.D., Ullrich M.S., Calvo J.S., Behnia F., Meloni G., Winkler D.D. Mutations in Superoxide Dismutase 1 (Sod1) Linked to Familial Amyotrophic Lateral Sclerosis Can Disrupt High-Affinity Zinc-Binding Promoted by the Copper Chaperone for Sod1 (Ccs) Molecules. 2020;25:1086. doi: 10.3390/molecules25051086.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25051086</ArticleId><ArticleId IdType="pmc">PMC7179120</ArticleId><ArticleId IdType="pubmed">32121118</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Okawa E., Watanabe S., Ono S.-I., Marklund S.L. Dysregulation of intracellular copper homeostasis is common to transgenic mice expressing human mutant superoxide dismutase-1s regardless of their copper-binding abilities. Neurobiol. Dis. 2013;54:308&#x2013;319. doi: 10.1016/j.nbd.2013.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.01.001</ArticleId><ArticleId IdType="pubmed">23321002</ArticleId></ArticleIdList></Reference><Reference><Citation>Tokuda E., Okawa E., Ono S.-I. Dysregulation of intracellular copper trafficking pathway in a mouse model of mutant copper/zinc superoxide dismutase-linked familial amyotrophic lateral sclerosis. J. Neurochem. 2009;111:181&#x2013;191. doi: 10.1111/j.1471-4159.2009.06310.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2009.06310.x</ArticleId><ArticleId IdType="pubmed">19656261</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney M.E., Pu H., Chiu A.Y., Canto M.C.D., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira F.G., Hatzipetros T., Thompson K., Moreno A.J., Kidd J.D., Tassinari V.R., Levine B., Perrin S., Gill A. CuATSM efficacy is independently replicated in a SOD1 mouse model of ALS while unmetallated ATSM therapy fails to reveal benefits. IBRO Rep. 2017;2:47&#x2013;53. doi: 10.1016/j.ibror.2017.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ibror.2017.03.001</ArticleId><ArticleId IdType="pmc">PMC6084867</ArticleId><ArticleId IdType="pubmed">30135932</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#x101;vere A.L., Lewis J.S. Cu-ATSM: A radiopharmaceutical for the PET imaging of hypoxia. Dalton Trans. 2007;43:4893&#x2013;4902. doi: 10.1039/b705989b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/b705989b</ArticleId><ArticleId IdType="pubmed">17992274</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., Yerbury M.R., Plotkin S.S. CuATSM Protects Against the In Vitro Cytotoxicity of Wild-Type- Like Copper-Zinc Superoxide Dismutase Mutants but not Mutants That Disrupt Metal Binding. ACS Chem. Neurosci. 2019;10:1555&#x2013;1564. doi: 10.1021/acschemneuro.8b00527.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.8b00527</ArticleId><ArticleId IdType="pubmed">30462490</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts B.R., Lim N.K.H., McAllum E.J., Donnelly P.S., Hare D.J., Doble P.A., Turner B.J., Price K.A., Lim S.C., Paterson B.M., et al. Oral Treatment with CuII(atsm) Increases Mutant SOD1 In Vivo but Protects Motor Neurons and Improves the Phenotype of a Transgenic Mouse Model of Amyotrophic Lateral Sclerosis. J. Neurosci. 2014;34:8021&#x2013;8031. doi: 10.1523/JNEUROSCI.4196-13.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4196-13.2014</ArticleId><ArticleId IdType="pmc">PMC6608261</ArticleId><ArticleId IdType="pubmed">24899723</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllum E.J., Lim N.K.-H., Hickey J.L., Paterson B.M., Donnelly P.S., Li Q.-X., Liddell J.R., Barnham K.J., White A.R., Crouch P.J. Therapeutic effects of CuII(atsm) in the SOD1-G37R mouse model of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2013;14:586&#x2013;590. doi: 10.3109/21678421.2013.824000.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.824000</ArticleId><ArticleId IdType="pubmed">23952668</ArticleId></ArticleIdList></Reference><Reference><Citation>McAllum E.J., Roberts B.R., Hickey J.L., Dang T.N., Grubman A., Donnelly P.S., Liddell J.R., White A.R., Crouch P.J. ZnII(atsm) is protective in amyotrophic lateral sclerosis model mice via a copper delivery mechanism. Neurobiol. Dis. 2015;81:20&#x2013;24. doi: 10.1016/j.nbd.2015.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.02.023</ArticleId><ArticleId IdType="pubmed">25766674</ArticleId></ArticleIdList></Reference><Reference><Citation>Ermilova I.P., Ermilov V.B., Levy M., Ho E., Pereira C., Beckman J.S. Protection by dietary zinc in ALS mutant G93A SOD transgenic mice. Neurosci. Lett. 2005;379:42&#x2013;46. doi: 10.1016/j.neulet.2004.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2004.12.045</ArticleId><ArticleId IdType="pubmed">15814196</ArticleId></ArticleIdList></Reference><Reference><Citation>Soon C.P., Donnelly P.S., Turner B.J., Hung L.W., Crouch P.J., Sherratt N.A., Tan J.-L., Lim N.K.-H., Lam L., Bica L., et al. Diacetylbis(N(4)-methylthiosemicarbazonato) Copper(II) (CuII(atsm)) Protects against Peroxynitrite-induced Nitrosative Damage and Prolongs Survival in Amyotrophic Lateral Sclerosis Mouse Model*. J. Biol. Chem. 2011;286:44035&#x2013;44044. doi: 10.1074/jbc.M111.274407.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.274407</ArticleId><ArticleId IdType="pmc">PMC3243559</ArticleId><ArticleId IdType="pubmed">22033929</ArticleId></ArticleIdList></Reference><Reference><Citation>Kensler T.W., Wakabayashi N., Biswal S. Cell survival responses to environmental stresses via the Keap1- Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 2007;47:89&#x2013;116. doi: 10.1146/annurev.pharmtox.46.120604.141046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.pharmtox.46.120604.141046</ArticleId><ArticleId IdType="pubmed">16968214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau A., Villeneuve N.F., Sun Z., Wong P.K., Zhang D.D. Dual roles of Nrf2 in cancer. Pharmacol. Res. 2008;58:262&#x2013;270. doi: 10.1016/j.phrs.2008.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2008.09.003</ArticleId><ArticleId IdType="pmc">PMC2652397</ArticleId><ArticleId IdType="pubmed">18838122</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D.D., Lo S.-C., Cross J.V., Templeton D.J., Hannink M. Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex. Mol. Cell. Biol. 2004;24:10941&#x2013;10953. doi: 10.1128/MCB.24.24.10941-10953.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.24.24.10941-10953.2004</ArticleId><ArticleId IdType="pmc">PMC533977</ArticleId><ArticleId IdType="pubmed">15572695</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon M., Thomas N., Itoh K., Yamamoto M., Hayes J.D. Redox-regulated Turnover of Nrf2 Is Determined by at Least Two Separate Protein Domains, the Redox-sensitive Neh2 Degron and the Redox-insensitive Neh6 Degron. J. Biol. Chem. 2004;279:31556&#x2013;31567. doi: 10.1074/jbc.M403061200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M403061200</ArticleId><ArticleId IdType="pubmed">15143058</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong K.I., Kobayashi A., Katsuoka F., Yamamoto M. Two-site substrate recognition model for the Keap1-Nrf2 system: A hinge and latch mechanism. Biol. Chem. 2006;387:1311&#x2013;1320. doi: 10.1515/BC.2006.164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/BC.2006.164</ArticleId><ArticleId IdType="pubmed">17081101</ArticleId></ArticleIdList></Reference><Reference><Citation>Kansanen E., Jyrkk&#xe4;nen H.-K., Levonen A.-L. Activation of stress signaling pathways by electrophilic oxidized and nitrated lipids. Free Radic. Biol. Med. 2012;52:973&#x2013;982. doi: 10.1016/j.freeradbiomed.2011.11.038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.11.038</ArticleId><ArticleId IdType="pubmed">22198184</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirby J., Halligan E., Baptista M.J., Allen S., Heath P.R., Holden H., Barber S.C., Loynes C.A., Wood-Allum C.A., Lunec J., et al. Mutant SOD1 alters the motor neuronal transcriptome: Implications for familial ALS. Brain. 2005;128:1686&#x2013;1706. doi: 10.1093/brain/awh503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh503</ArticleId><ArticleId IdType="pubmed">15872021</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarlette A., Krampfl K., Grothe C., Von Neuhoff N., Dengler R., Petri S. Nuclear Erythroid 2-Related Factor 2-Antioxidative Response Element Signaling Pathway in Motor Cortex and Spinal Cord in Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 2008;67:1055&#x2013;1062. doi: 10.1097/NEN.0b013e31818b4906.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31818b4906</ArticleId><ArticleId IdType="pubmed">18957896</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M., Vargas M.R., Robinson K.M., Cassina P., D&#xed;az-Amarilla P.J., Hagen T.M., Radi R., Barbeito L., Beckman J.S. Mitochondrial Superoxide Production and Nuclear Factor Erythroid 2-Related Factor 2 Activation in p75 Neurotrophin Receptor-Induced Motor Neuron Apoptosis. J. Neurosci. 2007;27:7777&#x2013;7785. doi: 10.1523/JNEUROSCI.0823-07.2007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0823-07.2007</ArticleId><ArticleId IdType="pmc">PMC6672870</ArticleId><ArticleId IdType="pubmed">17634371</ArticleId></ArticleIdList></Reference><Reference><Citation>Kraft A.D., Resch J.M., Johnson D.A., Johnson J.A. Activation of the Nrf2&#x2013;ARE pathway in muscle and spinal cord during ALS-like pathology in mice expressing mutant SOD1. Exp. Neurol. 2007;207:107&#x2013;117. doi: 10.1016/j.expneurol.2007.05.026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2007.05.026</ArticleId><ArticleId IdType="pmc">PMC2062571</ArticleId><ArticleId IdType="pubmed">17631292</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas M.R., Johnson D.A., Sirkis D.W., Messing A., Johnson J.A. Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis. J. Neurosci. 2008;28:13574&#x2013;13581. doi: 10.1523/JNEUROSCI.4099-08.2008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4099-08.2008</ArticleId><ArticleId IdType="pmc">PMC2866507</ArticleId><ArticleId IdType="pubmed">19074031</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y., Zhang Y., Wen D., Duan W., An T., Shi P., Wang J., Li Z., Chen X., Li C. The modest impact of transcription factor Nrf2 on the course of disease in an ALS animal model. Lab. Investig. 2013;93:825&#x2013;833. doi: 10.1038/labinvest.2013.73.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/labinvest.2013.73</ArticleId><ArticleId IdType="pubmed">23711824</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinkova-Kostova A.T., Holtzclaw W.D., Cole R.N., Itoh K., Wakabayashi N., Katoh Y., Yamamoto M., Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA. 2002;99:11908&#x2013;11913. doi: 10.1073/pnas.172398899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.172398899</ArticleId><ArticleId IdType="pmc">PMC129367</ArticleId><ArticleId IdType="pubmed">12193649</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong F., Freeman M.L., Liebler D.C. Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane. Chem. Res. Toxicol. 2005;18:1917&#x2013;1926. doi: 10.1021/tx0502138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/tx0502138</ArticleId><ArticleId IdType="pubmed">16359182</ArticleId></ArticleIdList></Reference><Reference><Citation>Schachtele S.J., Hu S., Lokensgard J.R. Modulation of experimental herpes encephalitis-associated neurotoxicity through sulforaphane treatment. PLoS ONE. 2012;7:e36216. doi: 10.1371/journal.pone.0036216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0036216</ArticleId><ArticleId IdType="pmc">PMC3338688</ArticleId><ArticleId IdType="pubmed">22558388</ArticleId></ArticleIdList></Reference><Reference><Citation>Steele M.L., Fuller S., Patel M., Kersaitis C., Ooi L., M&#xfc;nch G. Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cells. Redox Biol. 2013;1:441&#x2013;445. doi: 10.1016/j.redox.2013.08.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2013.08.006</ArticleId><ArticleId IdType="pmc">PMC3814960</ArticleId><ArticleId IdType="pubmed">24191238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou T.-T., Yang H.-Y., Wang W., Wu Q.-Q., Tian Y.-R., Jia J.-P. Sulforaphane Inhibits the Generation of Amyloid-&#x3b2; Oligomer and Promotes Spatial Learning and Memory in Alzheimer&#x2019;s Disease (PS1V97L) Transgenic Mice. J. Alzheimer&#x2019;s Dis. 2018;62:1803&#x2013;1813. doi: 10.3233/JAD-171110.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-171110</ArticleId><ArticleId IdType="pubmed">29614663</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauletti A., Terrone G., Shekh-Ahmad T., Salamone A., Ravizza T., Rizzi M., Pastore A., Pascente R., Liang L.-P., Villa B.R., et al. Targeting oxidative stress improves disease outcomes in a rat model of acquired epilepsy. Brain. 2019;142:e39. doi: 10.1093/brain/awz130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awz130</ArticleId><ArticleId IdType="pmc">PMC6598637</ArticleId><ArticleId IdType="pubmed">31145451</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwivedi S., Rajasekar N., Hanif K., Nath C., Shukla R. Sulforaphane Ameliorates Okadaic Acid-Induced Memory Impairment in Rats by Activating the Nrf2/HO-1 Antioxidant Pathway. Mol. Neurobiol. 2016;53:5310&#x2013;5323. doi: 10.1007/s12035-015-9451-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9451-4</ArticleId><ArticleId IdType="pubmed">26433376</ArticleId></ArticleIdList></Reference><Reference><Citation>Angeloni C., Malaguti M., Rizzo B., Barbalace M.C., Fabbri D., Hrelia S. Neuroprotective Effect of Sulforaphane against Methylglyoxal Cytotoxicity. Chem. Res. Toxicol. 2015;28:1234&#x2013;1245. doi: 10.1021/acs.chemrestox.5b00067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrestox.5b00067</ArticleId><ArticleId IdType="pubmed">25933243</ArticleId></ArticleIdList></Reference><Reference><Citation>Sedlak T.W., Nucifora L.G., Koga M., Shaffer L.S., Higgs C., Tanaka T., Wang A.M., Coughlin J.M., Barker P.B., Fahey J.W., et al. Sulforaphane Augments Glutathione and Influences Brain Metabolites in Human Subjects: A Clinical Pilot Study. Mol. Neuropsychiatry. 2018;3:214&#x2013;222. doi: 10.1159/000487639.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000487639</ArticleId><ArticleId IdType="pmc">PMC5981770</ArticleId><ArticleId IdType="pubmed">29888232</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuno K., Kume T., Muto C., Takada-Takatori Y., Izumi Y., Sugimoto H., Akaike A. Glutathione Biosynthesis via Activation of the Nuclear Factor E2&#x2013;Related Factor 2 (Nrf2)&#x2014;Antioxidant-Response Element (ARE) Pathway Is Essential for Neuroprotective Effects of Sulforaphane and 6-(Methylsulfinyl) Hexyl Isothiocyanate. J. Pharmacol. Sci. 2011;115:320&#x2013;328. doi: 10.1254/jphs.10257FP.</Citation><ArticleIdList><ArticleId IdType="doi">10.1254/jphs.10257FP</ArticleId><ArticleId IdType="pubmed">21358121</ArticleId></ArticleIdList></Reference><Reference><Citation>Jazwa A., Rojo A.I., Innamorato N.G., Hesse M., Fern&#xe1;ndez-Ruiz J., Cuadrado A. Pharmacological Targeting of the Transcription Factor Nrf2 at the Basal Ganglia Provides Disease Modifying Therapy for Experimental Parkinsonism. Antioxid. Redox Signal. 2011;14:2347&#x2013;2360. doi: 10.1089/ars.2010.3731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2010.3731</ArticleId><ArticleId IdType="pubmed">21254817</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Y., Yan W., Chen S., Sun C.-R., Zhang J.-M. The role of Nrf2 signaling in the regulation of antioxidants and detoxifying enzymes after traumatic brain injury in rats and mice. Acta Pharmacol. Sin. 2010;31:1421&#x2013;1430. doi: 10.1038/aps.2010.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/aps.2010.101</ArticleId><ArticleId IdType="pmc">PMC4003325</ArticleId><ArticleId IdType="pubmed">20953205</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., Luo L., Cai X., Fang Y., Wang J., Chen G., Yang J., Zhou Q., Sun X., Cheng X., et al. Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function. Free Radic. Biol. Med. 2018;120:13&#x2013;24. doi: 10.1016/j.freeradbiomed.2018.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2018.03.007</ArticleId><ArticleId IdType="pubmed">29530794</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi M., Li Q., Guo D., Ding X., Bi W., Zhang Y., Zou Y. Sulphoraphane improves neuronal mitochondrial function in brain tissue in acute carbon monoxide poisoning rats. Basic Clin. Pharmacol. Toxicol. 2017;120:541&#x2013;549. doi: 10.1111/bcpt.12728.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bcpt.12728</ArticleId><ArticleId IdType="pubmed">27983767</ArticleId></ArticleIdList></Reference><Reference><Citation>Luis-Garc&#xed;a E.R., Lim&#xf3;n-Pacheco J.H., Serrano-Garc&#xed;a N., Hern&#xe1;ndez-P&#xe9;rez A.D., Pedraza-Chaverri J., Orozco-Ibarra M. Sulforaphane prevents quinolinic acid-induced mitochondrial dysfunction in rat striatum. J. Biochem. Mol. Toxicol. 2017;31:e21837. doi: 10.1002/jbt.21837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbt.21837</ArticleId><ArticleId IdType="pubmed">27589053</ArticleId></ArticleIdList></Reference><Reference><Citation>Innamorato N.G., Rojo A.I., Garc&#xed;a-Yag&#xfc;e &#xc1;.J., Yamamoto M., De Ceballos M.L., Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J. Immunol. 2008;181:680&#x2013;689. doi: 10.4049/jimmunol.181.1.680.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.181.1.680</ArticleId><ArticleId IdType="pubmed">18566435</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin S., Yang C., Huang W., Du S., Mai H., Xiao J., L&#xfc; T. Sulforaphane attenuates microglia-mediated neuronal necroptosis through down-regulation of MAPK/NF-&#x3ba;B signaling pathways in LPS-activated BV-2 microglia. Pharmacol. Res. 2018;133:218&#x2013;235. doi: 10.1016/j.phrs.2018.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.01.014</ArticleId><ArticleId IdType="pubmed">29391237</ArticleId></ArticleIdList></Reference><Reference><Citation>Jang M., Cho I.H. Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-&#x3ba;B pathways. Mol. Neurobiol. 2016;53:261935. doi: 10.1007/s12035-015-9230-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-015-9230-2</ArticleId><ArticleId IdType="pubmed">26096705</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., Sharma S.S. Nrf2 and NF-&#x3ba;B Modulation by Sulforaphane Counteracts Multiple Manifestations of Diabetic Neuropathy in Rats and High Glucose-Induced Changes. Curr. Neurovasc. Res. 2011;8:294&#x2013;304. doi: 10.2174/156720211798120972.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/156720211798120972</ArticleId><ArticleId IdType="pubmed">22023613</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez-Rabaza V., Cabrera-Pastor A., Taoro-Gonzalez L., Gonzalez-Usano A., Agusti A., Balzano T., Llansola M., Felipo V. Neuroinflammation increases GABAergic tone and impairs cognitive and motor function in hyperammonemia by increasing GAT-3 membrane expression. Reversal by sulforaphane by promoting M2 polarization of microglia. J. Neuroinflamm. 2016;13:83. doi: 10.1186/s12974-016-0549-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-016-0549-z</ArticleId><ArticleId IdType="pmc">PMC4835883</ArticleId><ArticleId IdType="pubmed">27090509</ArticleId></ArticleIdList></Reference><Reference><Citation>Maciel-Bar&#xf3;n L.&#xc1;., Morales-Rosales S.L., Silva-Palacios A., Rodr&#xed;guez-Barrera R.H., Garc&#xed;a-&#xc1;lvarez J.A., Luna-L&#xf3;pez A., P&#xe9;rez V.I., Torres C., K&#xf6;nigsberg M. The secretory phenotype of senescent astrocytes isolated from Wistar newborn rats changes with anti-inflammatory drugs, but does not have a short-term effect on neuronal mitochondrial potential. Biogerontology. 2018;19:415&#x2013;433. doi: 10.1007/s10522-018-9767-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-018-9767-3</ArticleId><ArticleId IdType="pubmed">30097900</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J., Lee S., Choi B.-R., Yang H., Hwang Y., Park J.H.Y., LaFerla F.M., Han J.-S., Lee K.W., Kim J. Sulforaphane epigenetically enhances neuronal BDNF expression and TrkB signaling pathways. Mol. Nutr. Food Res. 2017;61:1600194. doi: 10.1002/mnfr.201600194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mnfr.201600194</ArticleId><ArticleId IdType="pubmed">27735126</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh S.-H., Lee S.M., Kim H.Y., Lee K.-Y., Lee Y.J., Kim H.-T., Kim J., Kim M.-H., Hwang M.S., Song C., et al. The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci. Lett. 2006;395:103&#x2013;107. doi: 10.1016/j.neulet.2005.10.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2005.10.056</ArticleId><ArticleId IdType="pubmed">16356650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Tu J., Zhang Q., Zhang X., Zhu Y., Ma W., Cheng C., Brann D.W., Yang F. Genistein attenuates ischemic oxidative damage and behavioral deficits via eNOS/Nrf2/HO-1 signaling. Hippocampus. 2013;23:634&#x2013;647. doi: 10.1002/hipo.22126.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hipo.22126</ArticleId><ArticleId IdType="pubmed">23536494</ArticleId></ArticleIdList></Reference><Reference><Citation>Satoh T., Kosaka K., Itoh K., Kobayashi A., Yamamoto M., Shimojo Y., Kitajima C., Cui J., Kamins J., Okamoto S.-I., et al. Carnosic acid, acatechol-typeelectrophilic compound, protects neurons bothin vitroandin vivothrough activation of the Keap1/Nrf2 pathway viaS-alkylation of targeted cysteines on Keap1. J. Neurochem. 2008;104:1116&#x2013;1131. doi: 10.1111/j.1471-4159.2007.05039.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.05039.x</ArticleId><ArticleId IdType="pmc">PMC4566957</ArticleId><ArticleId IdType="pubmed">17995931</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J.-H., Ou H.-P., Lin C.-Y., Lin F.-J., Wu C.-R., Chang S.-W., Tsai C.-W. Carnosic Acid Prevents 6-Hydroxydopamine-Induced Cell Death in SH-SY5Y Cells via Mediation of Glutathione Synthesis. Chem. Res. Toxicol. 2012;25:1893&#x2013;1901. doi: 10.1021/tx300171u.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/tx300171u</ArticleId><ArticleId IdType="pubmed">22894569</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Calingasan N.Y., Thomas B., Chaturvedi R.K., Kiaei M., Wille E.J., Liby K.T., Williams C., Royce D., Risingsong R., et al. Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription. PLoS ONE. 2009;4:e5757. doi: 10.1371/journal.pone.0005757.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005757</ArticleId><ArticleId IdType="pmc">PMC2684590</ArticleId><ArticleId IdType="pubmed">19484125</ArticleId></ArticleIdList></Reference><Reference><Citation>Neymotin A., Calingasan N.Y., Wille E., Naseri N., Petri S., Damiano M., Liby K.T., Risingsong R., Sporn M., Beal M.F., et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2011;51:88&#x2013;96. doi: 10.1016/j.freeradbiomed.2011.03.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2011.03.027</ArticleId><ArticleId IdType="pmc">PMC3109235</ArticleId><ArticleId IdType="pubmed">21457778</ArticleId></ArticleIdList></Reference><Reference><Citation>Marklund S.L. Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem. J. 1984;222:649&#x2013;655. doi: 10.1042/bj2220649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2220649</ArticleId><ArticleId IdType="pmc">PMC1144226</ArticleId><ArticleId IdType="pubmed">6487268</ArticleId></ArticleIdList></Reference><Reference><Citation>Chelikani P., Fita I., Loewen P.C. Diversity of structures and properties among catalases. Cell. Mol. Life Sci. 2004;61:192&#x2013;208. doi: 10.1007/s00018-003-3206-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-003-3206-5</ArticleId><ArticleId IdType="pubmed">14745498</ArticleId></ArticleIdList></Reference><Reference><Citation>Radi R., Turrens J., Chang L., Bush K., Crapo J., Freeman B. Detection of catalase in rat heart mitochondria. J. Biol. Chem. 1991;266:22028&#x2013;22034. doi: 10.1016/S0021-9258(18)54740-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)54740-2</ArticleId><ArticleId IdType="pubmed">1657986</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi A., Yan L.-J., Jana C.K., Das N. Role of Catalase in Oxidative Stress- and Age-Associated Degenerative Diseases. Oxidative Med. Cell. Longev. 2019;2019:1&#x2013;19. doi: 10.1155/2019/9613090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9613090</ArticleId><ArticleId IdType="pmc">PMC6885225</ArticleId><ArticleId IdType="pubmed">31827713</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhal A.B., Morris V.B., Labhasetwar V., Ghorpade A. Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis. 2013;4:e903. doi: 10.1038/cddis.2013.362.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cddis.2013.362</ArticleId><ArticleId IdType="pmc">PMC3847304</ArticleId><ArticleId IdType="pubmed">24201802</ArticleId></ArticleIdList></Reference><Reference><Citation>Dixon S.J., Patel D.N., Welsch M., Skouta R., Lee E.D., Hayano M., Thomas A.G., Gleason C.E., Tatonetti N.P., Slusher B.S., et al. Pharmacological inhibition of cystine&#x2013;glutamate exchange induces endoplasmic reticulum stress and ferroptosis. eLife. 2014;3:e02523. doi: 10.7554/eLife.02523.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.02523</ArticleId><ArticleId IdType="pmc">PMC4054777</ArticleId><ArticleId IdType="pubmed">24844246</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinholz M.M., Merkle C.M., Poduslo J.F. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis. Exp. Neurol. 1999;159:204&#x2013;216. doi: 10.1006/exnr.1999.7142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.1999.7142</ArticleId><ArticleId IdType="pubmed">10486188</ArticleId></ArticleIdList></Reference><Reference><Citation>Matouskova M., Ruttkay-Nedeck&#xfd; B., Kizek R. Antioxida&#x10d;n&#xed; enzymy-biochemick&#xe9; markery oxida&#x10d;n&#xed;ho stresu. J. Met. Nanotechnol. 2014;1:53&#x2013;56.</Citation></Reference><Reference><Citation>Kryukov G.V., Castellano S., Novoselov S.V., Lobanov A.V., Zehtab O., Guig&#xf3; R., Gladyshev V.N. Characterization of mammalian selenoproteomes. Science. 2003;300:1439&#x2013;1443. doi: 10.1126/science.1083516.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1083516</ArticleId><ArticleId IdType="pubmed">12775843</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H., Ran Q., Jang Y.C., Holstein D., Lechleiter J., McDonald-Marsh T., Musatov A., Song W., Van Remmen H., Richardson A. Glutathione peroxidase 4 differentially regulates the release of apoptogenic proteins from mitochondria. Free Radic. Biol. Med. 2009;47:312&#x2013;320. doi: 10.1016/j.freeradbiomed.2009.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2009.05.012</ArticleId><ArticleId IdType="pmc">PMC2773016</ArticleId><ArticleId IdType="pubmed">19447173</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterbourn C.C. Toxicity of iron and hydrogen peroxide: The Fenton reaction. Toxicol. Lett. 1995;82&#x2013;83:969&#x2013;974. doi: 10.1016/0378-4274(95)03532-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0378-4274(95)03532-X</ArticleId><ArticleId IdType="pubmed">8597169</ArticleId></ArticleIdList></Reference><Reference><Citation>Aisen P., Enns C., Wessling-Resnick M. Chemistry and biology of eukaryotic iron metabolism. Int. J. Biochem. Cell Biol. 2001;33:940&#x2013;959. doi: 10.1016/S1357-2725(01)00063-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1357-2725(01)00063-2</ArticleId><ArticleId IdType="pubmed">11470229</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W.S., SriRamaratnam R., Welsch M.E., Shimada K., Skouta R., Viswanathan V.S., Cheah J.H., Clemons P.A., Shamji A.F., Clish C.B., et al. Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell. 2014;156:317&#x2013;331. doi: 10.1016/j.cell.2013.12.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2013.12.010</ArticleId><ArticleId IdType="pmc">PMC4076414</ArticleId><ArticleId IdType="pubmed">24439385</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson W.M., Wilson-Delfosse A.L., Mieyal J.J. Dysregulation of Glutathione Homeostasis in Neurodegenerative Diseases. Nutrients. 2012;4:1399&#x2013;1440. doi: 10.3390/nu4101399.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu4101399</ArticleId><ArticleId IdType="pmc">PMC3497002</ArticleId><ArticleId IdType="pubmed">23201762</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L., Hambright W.S., Na R., Ran Q. Ablation of the Ferroptosis Inhibitor Glutathione Peroxidase 4 in Neurons Results in Rapid Motor Neuron Degeneration and Paralysis. J. Biol. Chem. 2015;290:28097&#x2013;28106. doi: 10.1074/jbc.M115.680090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.680090</ArticleId><ArticleId IdType="pmc">PMC4653669</ArticleId><ArticleId IdType="pubmed">26400084</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlson B.A., Tobe R., Yefremova E., Tsuji P.A., Hoffmann V.J., Schweizer U., Gladyshev V.N., Hatfield D.L., Conrad M. Glutathione peroxidase 4 and vitamin E cooperatively prevent hepatocellular degeneration. Redox Biol. 2016;9:22&#x2013;31. doi: 10.1016/j.redox.2016.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2016.05.003</ArticleId><ArticleId IdType="pmc">PMC4900515</ArticleId><ArticleId IdType="pubmed">27262435</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulatowski L.M., Manor D. Vitamin E and neurodegeneration. Neurobiol. Dis. 2015;84:78&#x2013;83. doi: 10.1016/j.nbd.2015.04.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2015.04.002</ArticleId><ArticleId IdType="pubmed">25913028</ArticleId></ArticleIdList></Reference><Reference><Citation>Kose T., Vera-Aviles M., Sharp P.A., Latunde-Dada G.O. Curcumin and (&#x2212;)- Epigallocatechin-3-Gallate Protect Murine MIN6 Pancreatic Beta-Cells Against Iron Toxicity and Erastin-Induced Ferroptosis. Pharmaceuticals. 2019;12:26. doi: 10.3390/ph12010026.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph12010026</ArticleId><ArticleId IdType="pmc">PMC6469157</ArticleId><ArticleId IdType="pubmed">30736288</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x160;t&#x11b;tk&#xe1;&#x159;ov&#xe1; I., Mat&#x11b;j R., Ehler E. Nov&#xe9; poznatky v dia&#xad;gnostice a l&#xe9;&#x10d;b&#x11b; amyotrofick&#xe9; later&#xe1;ln&#xed; skler&#xf3;zy. &#x10c;esk&#xe1; Slov. Neurol. Neurochir. 2018;81:546&#x2013;554. doi: 10.14735/amcsnn2018546.</Citation><ArticleIdList><ArticleId IdType="doi">10.14735/amcsnn2018546</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller T., Cudkowicz M., Shaw P.J., Andersen P.M., Atassi N., Bucelli R.C., Genge A., Glass J., Ladha S., Ludolph A.L., et al. Phase 1&#x2013;2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS. N. Engl. J. Med. 2020;383:109&#x2013;119. doi: 10.1056/NEJMoa2003715.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2003715</ArticleId><ArticleId IdType="pubmed">32640130</ArticleId></ArticleIdList></Reference><Reference><Citation>Paganoni S., Macklin E.A., Hendrix S., Berry J.D., Elliott M.A., Maiser S., Karam C., Caress J.B., Owegi M.A., Quick A., et al. Trial of sodium phenylbutyrate-taurursodiol for amyotrophic lateral sclerosis. N. Engl. J. Med. 2020;383:919&#x2013;930. doi: 10.1056/NEJMoa1916945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1916945</ArticleId><ArticleId IdType="pubmed">32877582</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>